Medicare’s exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence that Wegovy and similar drugs have health benefits beyond shedding pounds
Read Full Story
Latest posts by Market Watch (see all)
- U.S. stocks tiptoe lower early Monday after five weeks in rally mode - December 4, 2023
- : Twilio’s stock slides 2% after company announces to cut 5% of workforce - December 4, 2023
- EyePoint shares surge 300% in premarket after wet-AMD-treatment trial data - December 4, 2023